Objective biophysical findings in patients with sensitive skin

Drugs under Experimental and Clinical Research

Volumn 31, Issue SUPPL. VOL 31, 2005, Pages 17-24

  Roussaki Schulze, A V ^a   Zafiriou, E ^a   Nikoulis, D ^a   Klimi, E ^a   Rallis, E ^a,b   Zintzaras, E ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALI; ALLERGEN; DYE; IMMUNOGLOBULIN E; LACTIC ACID; METHACHOLINE; NICOTINIC ACID METHYL ESTER; NITRAZINE; SKIN LIPID; SODIUM HYDROXIDE; UNCLASSIFIED DRUG;

ADULT; ALKALI RESISTANCE TEST; ARTICLE; BIOPHYSICS; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DERMOGRAPHISM; DRY SKIN; FEMALE; HUMAN; HYDRATION; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOISTURE; NEUROSECRETION; PATCH TEST; PH MEASUREMENT; SEBUM; SENSITIVE SKIN; SKIN BLOOD VESSEL; SKIN DISEASE; SKIN PENETRATION; SKIN SENSITIVITY; SKIN TEST; STINGING TEST;

ADULT; BODY WATER; DERMATITIS, ALLERGIC CONTACT; DERMATITIS, IRRITANT; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; LIPIDS; MALE; MIDDLE AGED; SKIN; SKIN ABSORPTION; SKIN TESTS;

EID: 31344453163     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Seidenari S., Francomano M., Mantovani L. Baseline biophysical parameters in subjects with sensitive skin. Contact Dermatitis, 6, 311, 1998.
2. Draelos Z.D. Sensitive skin: Perceptions, evaluations and treatment. Am. J. Contact Dermat., 8, 67, 1997.
3. Muizzudin N., Marenus K.D., Maes D.H. Factors defining sensitive skin and its treatment. Am. J. Contact Dermat., 9, 170, 1998.
4. Simion F.A., Rau A.H. Sensitive skin: What is it and how to formulate for it. Cosmet. Toilet, 109, 43, 1994.
5. Hanifin J.M., Rajka G. Diagnostic features of atopic dermatitis. Acta. Derm. Venereol. (Stockh) 92(Suppl.), 44, 1980.
6. Braun Falco O., Plewig G., Wolff H.H., et al. (Eds.). "Dermatology." 2nd edition. Springer Verlag, Berlin-Heidelberg-New York, 2000, pp. 26-40, 431-568.
7. Idson B. In vivo measurements of transepidermal water loss. J. Soc. Cosmet. Chem., 29, 573, 1976.
8. Kurz R., Ummenhofer B. Localization on the integument and alkali resistance. Z. Hautkr., 57, 1019, 1982.
9. Bircher A.J. Skin pharmacology. In: Berardesca E., Elsner P., Maibach H.I. (Eds.). "Bioengineering of the Skin: Cutaneous Blood Flow and Erythema." CRC Series in Dermatology, 1995, pp. 73-84.
10. Messamore E., Hoffman W.F., Janowsky A. The niacin skin flush abnormality in schizophrenia: A quantitative dose-response study. Schizophrenia Research, 62, 251, 2003.
11. Klaschka F. "Empfindliche Haut." Diesbach Verlag, Berlin, 1992, pp. 1-94, 127-155.
12. Christensen M., Kligman A.M. An improved procedure for conducting lactic acid stinging test on facial skin. J. Soc. Cosmet. Chem., 47, 1, 1996.
13. Grove G., Soschin D., Kligman A.M. Guidelines for performing facial stinging test. Proc. 12th Congress Internat. Fed. Soc. Cosmet. Chem., Paris, 9, 13, 1982.
14. Uehara M., Ofuji S. Delayed blanch reaction in atopic dermatitis. Arch. Dermatol., 114, 1098, 1978.
15. Lobitz W.C., Campbell C.J. Physiological studies in atopic dermatitis: The local cutaneous response to intradermally injected acetylcholine and epinephrine. AMA Arch. Derm. Syphilol., 67, 575, 1953.
16. Petersen L.J., Skov P.S. Methacholine induces wheal-and-flare reactions in human skin but does not release histamine in vivo as assessed by the skin microdialysis technique. Allergy, 50, 976, 1995.
17. Lammintausta K., Maibach H.I., Wilson D. Susceptibility to cumulative and acute contact dermatitis. Contact Dermatitis, 19, 84, 1998.
18. Maibach H.I., Berardesca E. Racial and skin colour differences in skin sensitivity. Implications for skin care products. Cosmet. Toilet., 105, 35, 1990.
19. Weigand D.A., Haygood G., Gaylor J.R. Cell layers and density of Negro and Caucasian stratum corneum. J. Invest. Dermatol., 62, 563, 1974.
20. Berardesca E., Maibach H.I. Contact dermatitis in blacks. Dermatol. Clin., 6, 363, 1998.
21. Rienertson R.P., Wheatley V.R. Studies on the chemical composition of human epidermal lipids. J. Invest. Dermatol., 32, 49, 1959.
22. Berardesca E., Cespa M., Farinelli N., et al. In vivo transcutaneous penetration of nicotinates and sensitive skin. Contact Dermatitis, 25, 35 1991.
23. Kompaore F., Tsuruta H. In vivo differences between Asian, black and white in stratum corneum barrier function. Int. Arch. Occup. Environ. Health, 65, 223, 1993.
24. Misery L. Neuro-immuno-cutaneous system (NICS). Pathol. Biol. (Paris), 44, 867, 1996.
25. Misery L. Skin, immunity and nervous system. Br. J. Dermatol., 137, 843, 1997.
26. Claudy A. Neuromediators in dermatology. Therapeutic prospectives. Pathol. Biol. (Paris), 44, 888, 1996.
27. Luger T.A. Neuromediators - a crucial component of the skin immune system. J. Dermatol. Sci., 30, 87, 2002.
28. Black D. Barrier functions in atopic dermatitis and methods for its evaluation. Keratin, Privat Editions, 6, 4, 2002.
29. Scholzen T., Armstrong C.A., Bunett N.W., et al. Neuropeptides in the skin: Interactions between the neuroendocrine and the skin immune systems. Exp. Dermatol. 7, 81, 1998.
30. Luger T.A., Bhardwaj R.S., Grabbe S., et al. Regulation of the immune response by epidermal cytokines and neurohormones. J. Dermatol. Sci., 13, 5, 1996.